Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center

• Status: Unknown status
• Trial end date: 2019-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hermina Heart Center Kemayoran
• Treatments: Nitroglycerin; Parasympatholytics

Criteria

Inclusion Criteria:

• All patients undergoing transradial catheterisation using proximal radial artery puncture technique

Exclusion Criteria:

• Blood pressure <100 mmHg

• Refuse to participate